BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26216699)

  • 1. Will weight loss become a future treatment of hepatocellular adenoma in obese patients?
    Dokmak S; Belghiti J
    Liver Int; 2015 Oct; 35(10):2228-32. PubMed ID: 26216699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
    Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
    World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of hepatocellular adenoma after bariatric surgery in severe obese patients.
    Gevers TJG; Marcel Spanier BW; Veendrick PB; Vrolijk JM
    Liver Int; 2018 Dec; 38(12):2134-2136. PubMed ID: 30025198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection, transplantation and local regional therapies for liver adenomas.
    Dokmak S; Cauchy F; Belghiti J
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):803-10. PubMed ID: 24957321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of hepatocellular adenoma in obese patients: issues to consider.
    Yamaguchi T; Kokudo T; Zingg T; Halkic N
    Liver Int; 2016 Jan; 36(1):152. PubMed ID: 26386199
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
    Klompenhouwer AJ; Alblas M; van Rosmalen BV; Haring MPD; Venema E; Doukas M; Thomeer MGJ; Takkenberg RB; Verheij J; de Meijer VE; van Gulik TM; Lingsma HF; de Man RA; Ijzermans JNM
    Am J Gastroenterol; 2019 Aug; 114(8):1292-1298. PubMed ID: 30920416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to 'The management of hepatocellular adenoma in obese patients: issues to consider'.
    Dokmak S; Belghiti J
    Liver Int; 2016 Jan; 36(1):153. PubMed ID: 26767571
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
    Bunchorntavakul C; Bahirwani R; Drazek D; Soulen MC; Siegelman ES; Furth EE; Olthoff K; Shaked A; Reddy KR
    Aliment Pharmacol Ther; 2011 Sep; 34(6):664-74. PubMed ID: 21762186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should bariatric surgery be offered for hepatocellular adenomas in obese patients?
    Goonawardena J; Ratnayake C; Cheung KT; Fox A
    Surg Obes Relat Dis; 2020 Dec; 16(12):2117-2124. PubMed ID: 32771427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma subtypes: the impact of overweight and obesity.
    Bioulac-Sage P; Taouji S; Possenti L; Balabaud C
    Liver Int; 2012 Sep; 32(8):1217-21. PubMed ID: 22429502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Hepatocellular Adenoma: Recent Advances.
    Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.
    Erdogan D; Busch OR; van Delden OM; Ten Kate FJ; Gouma DJ; van Gulik TM
    Liver Int; 2006 May; 26(4):433-8. PubMed ID: 16629646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatocellular adenoma during pregnancy.
    Noels JE; van Aalten SM; van der Windt DJ; Kok NF; de Man RA; Terkivatan T; Ijzermans JN
    J Hepatol; 2011 Mar; 54(3):553-8. PubMed ID: 21094555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery.
    Dokmak S; Aussilhou B; Rasoaherinomenjanahary F; Ronot M; Dahdouh R; Ftériche FS; Cauchy F; Paradis V; Belghiti J; Soubrane O
    HPB (Oxford); 2018 Dec; 20(12):1198-1205. PubMed ID: 31217088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a decision-making model be justified in the management of hepatocellular adenoma?
    van Aalten SM; Witjes CD; de Man RA; Ijzermans JN; Terkivatan T
    Liver Int; 2012 Jan; 32(1):28-37. PubMed ID: 22098685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
    Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
    Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study on timing of resection of hepatocellular adenoma.
    Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
    Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign liver tumors].
    Cherqui D
    J Chir (Paris); 2001 Feb; 138(1):19-26. PubMed ID: 11240457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and liver adenoma management: PALM-study.
    van Aalten SM; Bröker ME; Busschbach JJ; de Koning HJ; de Man RA; Steegers EA; Steyerberg EW; Terkivatan T; Ijzermans JN
    BMC Gastroenterol; 2012 Jun; 12():82. PubMed ID: 22748109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.